Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel®

被引:0
|
作者
Laura S. Gold
Kangho Suh
Patricia B. Schepman
Kavitha Damal
Ryan N. Hansen
机构
[1] University of Washington,Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program
[2] University of Washington,Department of Radiology, Pharmaceutical Outcomes Research and Policy Program
[3] Regional Outcomes,Department of Health Services, Pharmaceutical Outcomes Research and Policy Program
[4] Sanofi U.S.,undefined
[5] Santen Incorporated,undefined
[6] University of Washington,undefined
来源
Advances in Therapy | 2016年 / 33卷
关键词
Costs; H.P. Acthar; gel (repository corticotropin injection); Healthcare resource utilization; Intravenous immunoglobulin; Multiple sclerosis; Neurology; Plasmapheresis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1279 / 1292
页数:13
相关论文
共 50 条
  • [31] Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment
    Tjalf Ziemssen
    Christine Prosser
    Jennifer Scarlet Haas
    Andrew Lee
    Sebastian Braun
    Pamela Landsman-Blumberg
    Angela Kempel
    Erika Gleißner
    Sarita Patel
    Ming-Yi Huang
    BMC Neurology, 17
  • [32] High Healthcare Resource Utilization and Costs Among Acromegaly Patients
    Guerin, Annie
    Xu, Yaping
    Hiscock, Robert
    Begelman, Susan M.
    Mu, Yunming
    Alaghband, Reza
    Wu, Eric Q.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [33] Long Term Follow-up Results of Myositis Patients Treated with H. P. Acthar Gel
    Saygin, Didem
    Marder, Galina
    Oddis, Chester V.
    Moghadam-Kia, Siamak
    Nandkumar, Preeya
    Qui, Zengbiao
    Koontz, Diane
    Aggarwal, Rohit
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [34] Utilization of the brief international cognitive assessment for multiple sclerosis during treatment of relapses in patients with multiple sclerosis
    Ozturk, O.
    Cinar, B. Piri
    Ozakbas, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E314 - E315
  • [35] Utilization of the Brief International Cognitive Assessment for Multiple Sclerosis during treatment of relapses in patients with multiple sclerosis
    Ozturk, O.
    Cinar, B. Piri
    Ozakbas, S.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 140 - 140
  • [36] Healthcare resource utilization and treatment costs of Finnish chronic inflammatory bowel disease patients treated with infliximab*
    Ylisaukko-Oja, Tero
    Torvinen, Saku
    Ventola, Hanna
    Schmidt, Saku
    Herrala, Sauli
    Kononoff, Jenni
    Voutilainen, Markku
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 726 - 732
  • [37] HIGHER RESOURCE UTILIZATION AND HEALTHCARE COSTS IN TREATED CHRONIC HEPATITIS B PATIENTS WITH CHRONIC KIDNEY DISEASE
    Nguyen, Mindie H.
    Lim, Joseph K.
    Liou, Iris
    Fraysse, Jeremy
    Meyer, Nicole
    Dusheiko, Geoffrey
    Gordon, Stuart C.
    GASTROENTEROLOGY, 2017, 152 (05) : S1087 - S1087
  • [38] COMPARISON OF HEALTHCARE RESOURCE UTILIZATION AND COSTS FOR WALDENSTROM'S MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB OR CHEMOIMMUNOTHERAPY
    Iyengar, R.
    Malangone-Monaco, E.
    Sugg, C.
    Arango-Hisijara, I
    Chen, Z.
    DeYoung, K.
    Chan, C.
    Giafis, N.
    VALUE IN HEALTH, 2019, 22 : S76 - S76
  • [39] RETROSPECTIVE DATABASE ANALYSIS OF FREQUENCY AND COSTS OF RELAPSES AMONG MULTIPLE SCLEROSIS PATIENTS
    Boklage, S.
    Preblick, R.
    Yaldo, A.
    Golick, M.
    Pocoski, J.
    VALUE IN HEALTH, 2011, 14 (03) : A211 - A212
  • [40] TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION (HRU) AMONG PATIENTS WITH MULTIPLE SCLEROSIS (MS) IN GERMANY TREATED WITH NABIXIMOLS BETWEEN 2010 AND 2020
    Freilich, J.
    Rodriguez-Rey, M. Delclaux
    Braune, S.
    Spelman, T.
    Yeramaneni, S.
    Drachenberg, C.
    VALUE IN HEALTH, 2022, 25 (12) : S123 - S123